Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
Use the vitals package with ellmer to evaluate and compare the accuracy of LLMs, including writing evals to test local models ...
But he might just as easily be describing the quiet conviction — held now by a growing number of founders, developers and technologists — that the Mac has become the most relevant, most usable, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results